WHO prequalifies Mylan's India unit to supply TB drug API

The WHO has prequalified Indian-based Mylan Laboratories Ltd to supply the tuberculosis drug ingredient protionamide.

To read the article in full, click here.


Source: in-PharmaTechnologist.com

To subscribe to the Weekly Newsletter of new posts, enter your email here:


By Gareth MacDonald

Published: July 26, 2017, 5:33 p.m.

Last updated: July 26, 2017, 5:36 p.m.

Print Share